Oxygenta Pharmaceutical Ltd — Results, 30-05-2025: Result

Oxygenta Pharmaceutical Limited has announced a board meeting on which it approved the audited financial results for the quarter and half-year. Revenue from operations rose significantly to Rs 49.47 Cr for the quarter, compared to Rs 10.55 Cr in the same period last year. However, the company reported a loss before tax of Rs 3.80 Cr for the quarter, wider than last year's Rs 2.59 Cr. The full year loss before tax stood at Rs 14.35 Cr versus Rs 13.87 Cr the prior year. The company shifted its corporate office within Hyderabad. Auditors issued an unmodified opinion on the results. The firm is focusing on improved MSME creditor identification and resolving aging schedule issues for better financial transparency.